INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill

Shares of Incyte (INCY) and Mirum Pharmaceuticals (MIRM) both eased on Friday after opening higher as traders waited for a weekend ruling from U.S. regulators on their shared rare-disease pill zilurgisertib.INCY opened up about 1% at about $126, and later traded in the low-$123s, leaving the roughl…